Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathobiologic effects of hepatitis C

M A Gerber1

  • 1Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Journal of Hepatology
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histopathology of HCV infection.

Clinics in liver disease·2004
Same author

Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients.

Chinese medical journal·2002
Same author

Prevention of hepatitis B in adolescents.

Pediatrics·2001
Same author

Intussusception, infection, and immunization: summary of a workshop on rotavirus.

Pediatrics·2001
Same author

New approaches to the treatment of group A streptococcal pharyngitis.

Current opinion in pediatrics·2001
Same author

HCV RNA levels in hepatocellular carcinomas and adjacent non-tumorous livers.

Journal of virological methods·2000
Same journal

Moving Too Fast? A Meta-Analysis Calls for Caution on TNF Inhibitors as First-Line Therapy for Autoimmune Hepatitis.

Journal of hepatology·2026
Same journal

Anserine restores antibacterial immunity in cirrhosis via a protective CCL5-mediated hepatocyte-CD44<sup>+</sup>pDC crosstalk.

Journal of hepatology·2026
Same journal

Anti-CCL2-conjugated platelets attenuate early allograft and ischemia-reperfusion injury by inhibiting monocyte infiltration.

Journal of hepatology·2026
Same journal

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

Journal of hepatology·2026
Same journal

Response to "Single-nucleus and spatial transcriptomic analyses reveal intra-tissue heterogeneity of PNPLA3".

Journal of hepatology·2026
Same journal

One-stop liquid biopsy: Can a single blood sample reveal the full spectrum of liver disease?

Journal of hepatology·2026
See all related articles

Hepatitis C virus (HCV) causes chronic hepatitis, potentially leading to cirrhosis and liver cancer (HCC). Research explores HCV

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Background:

  • Hepatitis C virus (HCV) is a primary cause of non-A, non-B hepatitis globally.
  • Chronic HCV infection can progress to liver cirrhosis and hepatocellular carcinoma (HCC).
  • Histologic hallmarks of chronic hepatitis C include bile duct injury and portal tract lymphoid aggregates.

Purpose of the Study:

  • To summarize the pathogenesis of chronic hepatitis C.
  • To review the association between HCV and hepatocellular carcinoma.
  • To discuss the role of viral and immune mechanisms in liver injury.

Main Methods:

  • Literature review of studies on Hepatitis C virus.
  • Analysis of histological findings in chronic hepatitis C.
  • Examination of the relationship between HCV and hepatocarcinogenesis.

Related Experiment Videos

Main Results:

  • HCV frequently causes chronic hepatitis, cirrhosis, and HCC.
  • Hepatocyte and bile duct injury involve direct viral effects and immune responses.
  • HCV is implicated in most HCC cases, often alongside HBV.

Conclusions:

  • HCV infection is a major global health concern with significant long-term consequences.
  • Understanding the mechanisms of HCV-induced liver damage is crucial.
  • The precise role of HCV in liver cancer development requires further investigation.